Phosphoinositide 3-kinase in health and disease Volume 2

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Rommel, Christian, Vanhaesebroeck, Bart, Vogt, Peter K.
Format: Electronic Resource
Language:English
Published: Berlin, Heidelberg Springer 2011.
Series:Current Topics in Microbiology and Immunology 347
Subjects:
Online Access:Available for University of the Philippines Diliman via SpringerLink. Click here to access